Bateman Terry Allan

Director at Ernexa Therapeutics Inc. · on record since Nov 4, 2008
CEO at Ernexa Therapeutics Inc. · on record since Feb 3, 2009

Insider trading activity of Bateman Terry Allan

Transactions on record: 11; since Nov 4, 2008

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Jun 11, 2012

Figures computed from official regulatory filings — .

Companies where Bateman Terry Allan has traded

Ernexa Therapeutics Inc.11 tx · $84.2K · Jun 11, 2012

Track record of Bateman Terry Allan

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Bateman Terry Allan

Co-insiders of Bateman Terry Allan

Angel MatthewErnexa Therapeutics Inc.
ARLEN GARY HErnexa Therapeutics Inc.
Arzt Michael AErnexa Therapeutics Inc.
AWM Investment Company, Inc.Ernexa Therapeutics Inc.
BENNETT ROBERT MErnexa Therapeutics Inc.
Berger KendraErnexa Therapeutics Inc.
Berg Jeffrey AlanErnexa Therapeutics Inc.
BERGSMAN BARRYErnexa Therapeutics Inc.
BINDER BRANTErnexa Therapeutics Inc.
Boozer JohnErnexa Therapeutics Inc.
Bourbiel JenniferErnexa Therapeutics Inc.
Boylan Peter James IIIErnexa Therapeutics Inc.
Bristol James ArthurErnexa Therapeutics Inc.
Buckner Mark DErnexa Therapeutics Inc.
BUSH MICHAEL JErnexa Therapeutics Inc.
CARRINO VINCENTErnexa Therapeutics Inc.
Chandler BarryErnexa Therapeutics Inc.
Cherington CharlesErnexa Therapeutics Inc.
Cicala PeterErnexa Therapeutics Inc.
Clarke Dorothy JErnexa Therapeutics Inc.
CLASEN ROBERT BErnexa Therapeutics Inc.
COONEY ROBERT JErnexa Therapeutics Inc.
Danilovic MarianaErnexa Therapeutics Inc.
DE GORTER MARKErnexa Therapeutics Inc.
DENNY GEORGE P IIIErnexa Therapeutics Inc.
Duckett Peter A.Ernexa Therapeutics Inc.
ELLIN ROBERT SErnexa Therapeutics Inc.
Farricielli Joseph J. Jr.Ernexa Therapeutics Inc.
Fidelity National Financial, Inc.Ernexa Therapeutics Inc.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Ernexa Therapeutics Inc.Listing on record	Jun 11, 2012	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ernexa Therapeutics Inc.Listing on record	Jun 20, 2011	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ernexa Therapeutics Inc.Listing on record	Jun 2, 2010	AwardD (derivative)	20,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ernexa Therapeutics Inc.Listing on record	Mar 22, 2010	ExerciseD (derivative)	328,125	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ernexa Therapeutics Inc.Listing on record	Mar 22, 2010	Exercise	328,125	0.17	$55.8K	Unusual size	SEC
Ernexa Therapeutics Inc.Listing on record	Jun 29, 2009	Exercise	145,833	0.17	$24.8K		SEC
Ernexa Therapeutics Inc.Listing on record	Jun 29, 2009	Exercise	30,000	0.12	$3.6K		SEC
Ernexa Therapeutics Inc.Listing on record	Jun 29, 2009	ExerciseD (derivative)	-145,833	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ernexa Therapeutics Inc.Listing on record	Jun 29, 2009	ExerciseD (derivative)	-30,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ernexa Therapeutics Inc.Listing on record	Feb 3, 2009	AwardD (derivative)	1,750,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ernexa Therapeutics Inc.Listing on record	Nov 4, 2008	AwardD (derivative)	30,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Ernexa Therapeutics Inc.Listing on record	Jun 11, 2012	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ernexa Therapeutics Inc.Listing on record	Jun 20, 2011	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ernexa Therapeutics Inc.Listing on record	Jun 2, 2010	AwardD (derivative)	20,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ernexa Therapeutics Inc.Listing on record	Mar 22, 2010	ExerciseD (derivative)	328,125	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ernexa Therapeutics Inc.Listing on record	Mar 22, 2010	Exercise	328,125	0.17	$55.8K	Unusual size	SEC
Ernexa Therapeutics Inc.Listing on record	Jun 29, 2009	Exercise	145,833	0.17	$24.8K		SEC
Ernexa Therapeutics Inc.Listing on record	Jun 29, 2009	Exercise	30,000	0.12	$3.6K		SEC
Ernexa Therapeutics Inc.Listing on record	Jun 29, 2009	ExerciseD (derivative)	-145,833	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ernexa Therapeutics Inc.Listing on record	Jun 29, 2009	ExerciseD (derivative)	-30,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ernexa Therapeutics Inc.Listing on record	Feb 3, 2009	AwardD (derivative)	1,750,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ernexa Therapeutics Inc.Listing on record	Nov 4, 2008	AwardD (derivative)	30,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC